Cargando…
YAP/TAZ: a promising target for squamous cell carcinoma treatment
Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) are two homologous transcriptional coactivators and the final effectors of the Hippo signaling transduction pathway. The transcriptional activity of YAP/TAZ is dependent on their recruitment to the nucleus, whi...
Autores principales: | Dong, Xiaoming, Meng, Lingbin, Liu, Pinyi, Ji, Rui, Su, Xuling, Xin, Ying, Jiang, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625644/ https://www.ncbi.nlm.nih.gov/pubmed/31360073 http://dx.doi.org/10.2147/CMAR.S197921 |
Ejemplares similares
-
Clinical significance of YAP1 and TAZ in esophageal squamous cell carcinoma
por: Liu, Li, et al.
Publicado: (2021) -
Expression and Clinical Significance of YAP, TAZ, and AREG in Hepatocellular Carcinoma
por: Han, Su-xia, et al.
Publicado: (2014) -
OTUB2 Regulates YAP1/TAZ to Promotes the Progression of Esophageal Squamous Cell Carcinoma
por: Liu, Li, et al.
Publicado: (2022) -
Anticancer Activity of Sulforaphane: The Epigenetic Mechanisms and the Nrf2 Signaling Pathway
por: Su, Xuling, et al.
Publicado: (2018) -
Sulforaphane prevents angiotensin II‐induced cardiomyopathy by activation of Nrf2 through epigenetic modification
por: Su, Xuling, et al.
Publicado: (2021)